Status:
COMPLETED
Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Myopia
Eligibility:
All Genders
7-14 years
Phase:
PHASE4
Brief Summary
Orthokeratology is becoming popular for the treatment of myopia children. Many studies have shown that orthokeratology is effective in temporarily reducing refractive error, and is also helpful for co...
Eligibility Criteria
Inclusion
- Ages Eligible for Study: 7 Years to 14 Years
- Genders Eligible for Study: Both
- Visual acuity 20/20 or better in each eye
- Spherical error ranging from -0.5 D to -5.0 D and astigmatism less than 1.5 D in each eye, anisometropia less than 1.0 D between the two eyes
- No strabismus, amblyopia and any other ocular or systematic diseases that may affect refractive development
Exclusion
- Currently or history using other interventions to control myopia progression (acupuncture, drugs, contact lens, ear needles and so on)
- Unable to cooperate with the ocular examination,questionnaire survey,or orthokeratology wearing
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02186184
Start Date
June 1 2014
End Date
October 1 2017
Last Update
December 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospital
Beijing, Beijing Municipality, China, 100730